Home    Back

Cd62l- tem    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
60Aplastic anemia1

60. Aplastic anemia    [ 218 clinical trials,   362 drugs,   (DrugBank: 81 drugs),   39 drug target genes,   155 drug target pathways]
Searched query = "Aplastic anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 218 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03836690
(ClinicalTrials.gov)		October 21, 201910/1/2019Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationPhase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell TransplantationLymphoma;Leukemia;Myeloma;Myelodysplastic Syndromes;Severe Aplastic Anemia;Primary Immune Deficiency;Graft Vs Host DiseaseBiological: CD62L- TemUniversity College, LondonMedical Research CouncilRecruiting16 Years70 YearsAll18Phase 1United Kingdom